Molecular characterization of Richter syndrome identifies de novo diffuse large B-cell lymphomas with poor prognosis
暂无分享,去创建一个
A. Rosenwald | A. Mottok | G. Ott | R. Houlgatte | J. Martín-Subero | P. Lichter | D. Meyre | P. Feugier | S. Bernhart | S. Stilgenbauer | M. Béné | Anne Quinquenel | Sébastien Hergalant | J. Broséus | O. Ammerpohl | F. Davi | A. Delmer | M. Kreuz | E. Chapiro | O. Tournilhac | F. Nguyen‐Khac | C. Dartigeas | C. Chéry | O. Blanchet | C. Thieblemont | Pierre Rouyer | C. Schneider | J. Vogt | M. Hunault | E. Tausch | S. Lomazzi | F. Cymbalista | C. Tomowiak | G. Gauchotte | G. Lazarian | Charline Moulin | R. Siebert | J. Guéant | E. Chteinberg | D. Roos-Weil | R. Guièze
[1] D. Torrents,et al. Detection of early seeding of Richter transformation in chronic lymphocytic leukemia , 2022, Nature Medicine.
[2] L. Staudt,et al. Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL. , 2021, Cancer cell.
[3] R. Siebert,et al. Clinical, biological, and molecular genetic features of Richter syndrome and prognostic significance: A study of the French Innovative Leukemia Organization , 2021, American journal of hematology.
[4] Jules N. A. Kerssemakers,et al. Mutational mechanisms shaping the coding and noncoding genome of germinal center derived B-cell lymphomas , 2021, Leukemia.
[5] Brijesh Singh Yadav,et al. B Cell Receptor signaling and genetic lesions in TP53 and CDKN2A/CDKN2B cooperate in Richter Transformation. , 2021, Blood.
[6] S. Deaglio,et al. Synergistic efficacy of dual PI3K-d/g inhibitor Duvelisib with Bcl2 inhibitor Venetoclax in Richter's Syndrome PDX models. , 2021, Blood.
[7] M. Ko,et al. ROR1 targeting with the antibody drug-conjugate VLS-101 is effective in Richter syndrome patient-derived xenograft mouse models. , 2021, Blood.
[8] A. Jemal,et al. Cancer Statistics, 2021 , 2021, CA: a cancer journal for clinicians.
[9] E. McDonagh,et al. Open Targets Platform: supporting systematic drug–target identification and prioritisation , 2020, Nucleic Acids Res..
[10] P. Feugier,et al. Microenvironment Remodeling and Subsequent Clinical Implications in Diffuse Large B-Cell Histologic Variant of Richter Syndrome , 2020, Frontiers in Immunology.
[11] S. Stilgenbauer,et al. U-RT1 – A new model for Richter transformation , 2020, Neoplasia.
[12] N. Popitsch,et al. Genomic and transcriptomic correlates of Richter's transformation in Chronic Lymphocytic Leukemia. , 2020, Blood.
[13] Ryan D. Morin,et al. A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications. , 2020, Cancer cell.
[14] P. Lena,et al. Methylation data imputation performances under different representations and missingness patterns , 2020, BMC Bioinformatics.
[15] E. Giné,et al. The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome , 2019, Nature Cancer.
[16] R. Houlgatte,et al. Ki‐67 and MCM6 labeling indices are correlated with overall survival in anaplastic oligodendroglioma, IDH1‐mutant and 1p/19q‐codeleted: a multicenter study from the French POLA network , 2019, Brain pathology.
[17] C. Copie-Bergman,et al. Refining diffuse large B-cell lymphoma subgroups using integrated analysis of molecular profiles , 2019, EBioMedicine.
[18] Tamara J. Blätte,et al. IGF1R as druggable target mediating PI3K-δ inhibitor resistance in a murine model of chronic lymphocytic leukemia. , 2019, Blood.
[19] Sébastien Hergalant,et al. Folate can promote the methionine-dependent reprogramming of glioblastoma cells towards pluripotency , 2019, Cell Death & Disease.
[20] Othman Soufan,et al. NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis , 2019, Nucleic Acids Res..
[21] Damian Szklarczyk,et al. STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets , 2018, Nucleic Acids Res..
[22] Astrid Gall,et al. Ensembl 2019 , 2018, Nucleic Acids Res..
[23] T. Hughes,et al. The Human Transcription Factors , 2018, Cell.
[24] W. Tam,et al. Novel Richter Syndrome Xenograft Models to Study Genetic Architecture, Biology, and Therapy Responses. , 2018, Cancer research.
[25] J. Byrd,et al. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. , 2018, Blood.
[26] Bas T. Heijmans,et al. omicsPrint: detection of data linkage errors in multiple omics studies , 2018, Bioinform..
[27] Sébastien Hergalant,et al. Wnt Signaling Pathways Are Dysregulated in Rat Female Cerebellum Following Early Methyl Donor Deficiency , 2018, Molecular Neurobiology.
[28] R. Guigó,et al. The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia , 2018, Nature Medicine.
[29] Stefano Monti,et al. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes , 2018, Nature Medicine.
[30] T. Shanafelt,et al. Chronic lymphocytic leukaemia , 2018, The Lancet.
[31] Roland Schmitz,et al. Genetics and Pathogenesis of Diffuse Large B‐Cell Lymphoma , 2018, The New England journal of medicine.
[32] D. Dunson,et al. Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma , 2017, Cell.
[33] D. Trono,et al. KRAB zinc finger proteins , 2017, Development.
[34] J. Gribben,et al. Chronic lymphocytic leukaemia , 2017, Nature Reviews Disease Primers.
[35] A. Schuh,et al. Diagnostic dilemmas of high‐grade transformation (Richter's syndrome) of chronic lymphocytic leukaemia: results of the phase II National Cancer Research Institute CHOP‐OR clinical trial specialist haemato‐pathology central review , 2016, Histopathology.
[36] E. Giné,et al. Decoding the DNA Methylome of Mantle Cell Lymphoma in the Light of the Entire B Cell Lineage. , 2016, Cancer cell.
[37] Timothy J. Peters,et al. Critical evaluation of the Illumina MethylationEPIC BeadChip microarray for whole-genome DNA methylation profiling , 2016, Genome Biology.
[38] Andrew D. Rouillard,et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update , 2016, Nucleic Acids Res..
[39] J. Josse,et al. missMDA: A Package for Handling Missing Values in Multivariate Data Analysis , 2016 .
[40] Guangchuang Yu,et al. ReactomePA: an R/Bioconductor package for reactome pathway analysis and visualization. , 2016, Molecular bioSystems.
[41] J. Byrd,et al. DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia , 2016, Nature Genetics.
[42] Jovana Maksimovic,et al. missMethyl: an R package for analyzing data from Illumina's HumanMethylation450 platform , 2016, Bioinform..
[43] Roland Eils,et al. DNA methylome analysis in Burkitt and follicular lymphomas identifies differentially methylated regions linked to somatic mutation and transcriptional control , 2015, Nature Genetics.
[44] T. Somervaille,et al. Frequent Derepression of the Mesenchymal Transcription Factor Gene FOXC1 in Acute Myeloid Leukemia. , 2015, Cancer cell.
[45] Ronald P. Schuyler,et al. Whole-genome fingerprint of the DNA methylome during human B cell differentiation , 2015, Nature Genetics.
[46] Steven L Salzberg,et al. HISAT: a fast spliced aligner with low memory requirements , 2015, Nature Methods.
[47] S. Salzberg,et al. StringTie enables improved reconstruction of a transcriptome from RNA-seq reads , 2015, Nature Biotechnology.
[48] Olivier Elemento,et al. Epigenomic evolution in diffuse large B-cell lymphomas , 2013, Nature Communications.
[49] Peter L Molloy,et al. De novo identification of differentially methylated regions in the human genome , 2015, Epigenetics & Chromatin.
[50] E. Giné,et al. A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact , 2014, Leukemia.
[51] Rafael A. Irizarry,et al. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays , 2014, Bioinform..
[52] R. Gascoyne,et al. Variability in DNA methylation defines novel epigenetic subgroups of DLBCL associated with different clinical outcomes. , 2014, Blood.
[53] Michael Frank Harris,et al. Lymphoma , 1990, BMJ : British Medical Journal.
[54] Charity W. Law,et al. voom: precision weights unlock linear model analysis tools for RNA-seq read counts , 2014, Genome Biology.
[55] Raul Rabadan,et al. Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome , 2013, The Journal of experimental medicine.
[56] W. Chan,et al. Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome. , 2013, Blood.
[57] A E Giuliano,et al. FOXC1 regulates the functions of human basal-like breast cancer cells by activating NF-κB signaling , 2012, Oncogene.
[58] Xiaomei Ma,et al. A global DNA methylation and gene expression analysis of early human B-cell development reveals a demethylation signature and transcription factor network , 2012, Nucleic acids research.
[59] Alfonso Valencia,et al. Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia , 2012, Nature Genetics.
[60] A. Oshlack,et al. SWAN: Subset-quantile Within Array Normalization for Illumina Infinium HumanMethylation450 BeadChips , 2012, Genome Biology.
[61] K. Gunderson,et al. High density DNA methylation array with single CpG site resolution. , 2011, Genomics.
[62] S. Pileri,et al. The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation. , 2011, Blood.
[63] O. Elemento,et al. DNA methylation signatures define molecular subtypes of diffuse large B-cell lymphoma. , 2010, Blood.
[64] Francesco Bertoni,et al. Genomic profiling of Richter's syndrome: recurrent lesions and differences with de novo diffuse large B‐cell lymphomas , 2009, Hematological oncology.
[65] M. Robinson,et al. A scaling normalization method for differential expression analysis of RNA-seq data , 2010, Genome Biology.
[66] A. Visel,et al. Genomic Views of Distant-Acting Enhancers , 2009, Nature.
[67] E. Birney,et al. Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt , 2009, Nature Protocols.
[68] J. Sarkaria,et al. Evaluation of MGMT promoter methylation status and correlation with temozolomide response in orthotopic glioblastoma xenograft model , 2009, Journal of Neuro-Oncology.
[69] L. Staudt,et al. Stromal gene signatures in large-B-cell lymphomas. , 2008, The New England journal of medicine.
[70] A. Rosenwald,et al. IgVH Mutational Status and Clonality Analysis of Richter's Transformation: Diffuse Large B-cell Lymphoma and Hodgkin Lymphoma in Association With B-cell Chronic Lymphocytic Leukemia (B-CLL) Represent 2 Different Pathways of Disease Evolution , 2007, The American journal of surgical pathology.
[71] Sean R. Davis,et al. GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor , 2007, Bioinform..
[72] Adrian Wiestner,et al. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[73] S. Goodman,et al. Hypermethylation of the DNA repair gene O(6)-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma. , 2002, Journal of the National Cancer Institute.
[74] Ash A. Alizadeh,et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.